HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

WHO highlights global threat of NCDs, need for action at Moscow meeting

Non-communicable diseases are a "slow-moving catastrophe" that could overwhelm even the richest countries without action to address their underlying causes, WHO Director-General Margaret Chan said at the First Global Ministerial Conference on Healthy Lifestyles and Non-communicable Disease Control in Moscow on Thursday, the U.N. News Centre reports.

30 Apr 2011

Also in global health news: Libya food shortage; PMTCT in Swaziland; TB detection in U.K.; food issues in Foreign Policy magazine

Libya will run out of food within two months unless efforts are stepped up to get shipments into the war-torn country, the World Food Program warned on Thursday, Deustche Presse-Agentur/M&C reports.

30 Apr 2011

NeurogesX first quarter revenue is $3.2 million for 2011

NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today reported results for its first quarter ended March 31, 2011.

30 Apr 2011

Portuguese researcher to earn Bill & Melinda Gates Foundation award for new HIV therapy

João Gonçalves, from Faculdade de Farmácia e Instituto de Medicina Molecular, Lisbon, Portugal, to win a Grand Challenges Exploration Award

29 Apr 2011

Bill & Melinda Gates Foundation honors University Of Colorado researcher for preeclampsia study

A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.

29 Apr 2011

New innovative pilot project to combat surgical infections

Roughly one out of every 24 patients undergoing surgery acquires a surgical site infection. With 40 million operations performed in the U.S. each year, between 800,000 and 2 million individuals contract these infections annually.

29 Apr 2011

PURE Bioscience introduces new Hard Surface disinfectant

PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate antimicrobial, today announced the launch of its proprietary new brand, PURE Hard Surface disinfectant and food contact surface sanitizer at the 2011 California State PTA Annual Convention being held April 28 - May 1 in Long Beach, California.

28 Apr 2011

Panel speakers to discuss hepatitis C prevention, treatment at Mayes College event

Mayes College of Healthcare Business and Policy at University of the Sciences is hosting a panel discussion on hepatitis C prevention and treatment, on Thursday, April 28, 2011, from 5 to 7 p.m.

28 Apr 2011

Non-communicable diseases responsible for more than half of deaths worldwide, WHO report says

Chronic and non-communicable illnesses, such as cancer, diabetes and heart disease, are at epidemic proportions and cause more deaths worldwide than all other diseases combined, the WHO said in a report released Wednesday, Reuters reports.

28 Apr 2011

IL28B gene plays a key role in spontaneous HCV clearance in infants

New research shows that high maternal viral load and co-infection with human immunodeficiency virus are the only risk factors associated with vertical transmission of the hepatitis C virus.

28 Apr 2011

Seattle BioMed study to identify biomarkers for malaria vaccine design

In the first study of its type in the malaria field, Seattle BioMed has been awarded an $8.9 million grant from the Bill & Melinda Gates Foundation to identify biomarkers that will allow malaria vaccine design based on robust predictors of protective immunity.

28 Apr 2011

MSF letter criticizes Johnson & Johnson for not joining Medicines Patent Pool

Medecins Sans Frontieres recently sent a letter to Johnson & Johnson criticizing the pharmaceutical company for "refusing to make patents on three HIV drugs available to a program that would reduce the cost of the medicines in developing countries," the Star-Ledger reports.

27 Apr 2011

Biomagnetics accepts Los Alamos National Labs' optical biosensor for disease diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced it has accepted delivery of the world's first integrated optical biosensor for disease diagnosis.

27 Apr 2011

Boehringer Ingelheim initiates enrollment in BI 201335 Phase 3 clinical trial for chronic HCV

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that enrollment has commenced at North American sites in its pivotal Phase 3 clinical trial program for BI 201335, the Company's investigational, oral protease inhibitor for the treatment of chronic hepatitis C virus (HCV).

27 Apr 2011

African-American couples with HIV can benefit from health promotion interventions

Interventions to promote healthy behaviors, including eating more fruits and vegetables, increasing physical activity, and participating in cancer screenings, as well as prevention of HIV/sexually transmitted diseases, appear beneficial for African-American couples who are at high risk for chronic diseases, especially if one of the individuals is living with HIV.

26 Apr 2011

Men with high DHA levels may face risk of developing aggressive prostate cancer

The largest study ever to examine the association of dietary fats and prostate cancer risk has found what's good for the heart may not be good for the prostate.

26 Apr 2011

Study: More couple-based HIV counseling needed in South Africa

A new study of sexual risk behaviors within long-term couples in South Africa finds that HIV-positive people take almost as much risk in their sexual behavior when they know their partner is HIV-negative or don't know their status, as when they know their partner is already infected.

26 Apr 2011

Study: HIV infection linked to increased risk of heart failure

Patients with HIV infection without a prior history of coronary heart disease may be at a higher risk of developing heart failure, according to a report in the April 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

26 Apr 2011

Study questions suitability of anti-retroviral drugs for the young

According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.

25 Apr 2011

Africa's football leaders earn UAM recognition for combating malaria

Today on World Malaria Day, the United Against Malaria campaign, under the Roll Back Malaria Partnership, recognized leaders from Africa's football and corporate spheres for their role in bringing malaria control messages to more than two billion 2010 World Cup spectators through public service announcements and media, and to 10 million employees through "Malaria Safe" corporate initiatives.

25 Apr 2011

HIV/AIDS News and Research

Further Reading

WHO highlights global threat of NCDs, need for action at Moscow meeting

Also in global health news: Libya food shortage; PMTCT in Swaziland; TB detection in U.K.; food issues in Foreign Policy magazine

NeurogesX first quarter revenue is $3.2 million for 2011

Portuguese researcher to earn Bill & Melinda Gates Foundation award for new HIV therapy

Bill & Melinda Gates Foundation honors University Of Colorado researcher for preeclampsia study

New innovative pilot project to combat surgical infections

PURE Bioscience introduces new Hard Surface disinfectant

Panel speakers to discuss hepatitis C prevention, treatment at Mayes College event

Non-communicable diseases responsible for more than half of deaths worldwide, WHO report says

IL28B gene plays a key role in spontaneous HCV clearance in infants

Seattle BioMed study to identify biomarkers for malaria vaccine design

MSF letter criticizes Johnson & Johnson for not joining Medicines Patent Pool

Biomagnetics accepts Los Alamos National Labs' optical biosensor for disease diagnosis

Boehringer Ingelheim initiates enrollment in BI 201335 Phase 3 clinical trial for chronic HCV

African-American couples with HIV can benefit from health promotion interventions

Men with high DHA levels may face risk of developing aggressive prostate cancer

Study: More couple-based HIV counseling needed in South Africa

Study: HIV infection linked to increased risk of heart failure

Study questions suitability of anti-retroviral drugs for the young

Africa's football leaders earn UAM recognition for combating malaria

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News